A novel IGF-targeting protein (IGF-Trap) has been demonstrated to markedly block CRLM in experimental models to compensate for the function of the impaired insulin receptor system, thus inducing tumour cell apoptosis and reducing angiogenesis [121]. The gene discussed is IGF1; the disease is neoplasm.